Gender-specific effects on food intake but no inhibition of age-related fat accretion in transgenic mice overexpressing human IGFBP-2 lacking the Cardin-Weintraub sequence motif

Journal of Cell Communication and Signaling

Volumn 9, Issue 2, 2015, Pages 143-150

  Wiedmer, Petra ^a   Schwarz, Franziska ^a   Große, Birgit ^a   Schindler, Nancy ^b   Tuchscherer, Armin ^b   Russo, Vincenzo C ^c   Tschöp, Matthias H ^d   Hoeflich, Andreas ^b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Age; Energy; Food intake; Gender; Growth; Heparin; IGFBP 2; Metabolism; Mouse; Obesity; Transgenic

Indexed keywords

HEPARIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY FAT; BODY GROWTH; BODY WEIGHT; CONTROLLED STUDY; ENERGY METABOLISM; FAT MASS; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; IGFBP2 GENE; LEAN BODY WEIGHT; LONGITUDINAL STUDY; MALE; METABOLIC RATE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ONLINE MONITORING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; SEX DIFFERENCE; TIME; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

EID: 84930541720     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-015-0264-z     Document Type: Article

References (31)

1. Arai T, Busby W Jr, Clemmons DR (1996) Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology 137:4571–4575
2. Asarian L, Geary N (2013) Sex differences in the physiology of eating. Am J Physiol Regul Integr Comp Physiol 305:R1215–R1267
3. Boudry C, Dehoux JP, Colinet FG, Wavreille J, Portetelle D, Beckers Y, Théwis A (2010) Effect of bovine colostrum on the serum insulin-like growth factor-I (IGF-I), the IGF binding proteins-2 and −3 and the thyroid hormones in weaning piglets. Archiv Tierzucht 53:675–688
4. Choleris E, Cazzin L, Lymer JM, Amor TR, Lu R, Kavaliers M, Valsecchi P (2013) Acute corticosterone sexually dimorphically facilitates social learning and inhibits feeding in mice. Neuropharmacology 75:191–200
5. Davis KE, Carstens EJ, Irani BG, Gent LM, Hahner LM, Clegg DJ (2014) Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis. Horm Behav 66:196–207
6. DeMambro VE, Clemmons DR, Horton LG, Bouxsein ML, Wood TL, Beamer WG, Canalis E, Rosen CJ (2008) Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology 149:2051–2061
7. DeMambro VE, Maile L, Wai C, Kawai M, Cascella T, Rosen CJ, Clemmons D (2012) Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation. J Bone Miner Res 27:390–400
8. Eckstein F, Pavicic T, Nedbal S, Schmidt C, Wehr U, Rambeck W, Wolf E, Hoeflich A (2002) Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice. Anat Embryol (Berl) 206:139–148
9. Foulstone EJ, Zeng L, Perks CM, Holly JM (2013) Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor. Endocrinology 154:1780–1793
10. Hedbacker K, Birsoy K, Wysocki RW, Asilmaz E, Ahima RS, Farooqi IS, Friedman JM (2010) Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 11:11–22
11. Hoeflich A (2008) Contrasting bone effects of temporary versus permanent IGFBP administration in rodents. Growth Horm IGF Res 18:181–187
12. Hoeflich A, Wu M, Mohan S, Foll J, Wanke R, Froehlich T, Arnold GJ, Lahm H, Kolb HJ, Wolf E (1999) Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140:5488–5496
13. Hoeflich A, Nedbal S, Blum WF, Erhard M, Lahm H, Brem G, Kolb HJ, Wanke R, Wolf E (2001) Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology 142:1889–1898
14. Hoeflich A, Wirthgen E, David R, Classen CF, Spitschak M, and Brenmoehl J (2014). Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates. Front Endocrinol. (Lausanne) 5: 43
15. Khosla S (2008) Insulin-like growth factor binding protein-2: a novel regulator of skeletal gender differences? Endocrinology 149:2048–2050
16. Kratzsch J, Blum WF, Schenker E, Keller E, Jahreis G, Haustein B, Ventz M, Rotzsch W (1993) Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay. Exp Clin Endocrinol 101:144–149
17. Kuang Z, Yao S, Keizer DW, Wang CC, Bach LA, Forbes BE, Wallace JC, Norton RS (2006) Structure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2). J Mol Biol 364:690–704
18. Munoz-Gutierrez M, Findlay PA, Adam CL, Wax G, Campbell BK, Kendall NR, Khalid M, Forsberg M, Scaramuzzi RJ (2005) The ovarian expression of mRNAs for aromatase, IGF-I receptor, IGF-binding protein-2, −4 and −5, leptin and leptin receptor in cycling ewes after three days of leptin infusion. Reproduction 130:869–881
19. Rehfeldt C, Renne U, Sawitzky M, Binder G, Hoeflich A (2010) Increased fat mass, decreased myofiber size, and a shift to glycolytic muscle metabolism in adolescent male transgenic mice overexpressing IGFBP-2. Am J Physiol Endocrinol Metab 299:E287–E298
20. Russo VC, Bach LA, Fosang AJ, Baker NL, Werther GA (1997) Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology 138:4858–4867
21. Russo VC, Schütt BS, Andaloro E, Ymer SI, Hoeflich A, Fosang AJ, Ranke MB, Bach LA, and Werther GA (2004). Proteoglycan complexes in the rat brain olfactory bulb. Proceedings 12th International congress of Endocrinology
22. Russo VC, Schutt BS, Andaloro E, Ymer SI, Hoeflich A, Ranke MB, Bach LA, Werther GA (2005) Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. Endocrinology 146:4445–4455
23. Sartorius T, Peter A, Schulz N, Drescher A, Bergheim I, Machann J, Schick F, Siegel-Axel D, Schurmann A, Weigert C, Haring HU, Hennige AM (2014) Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity. PLoS One 9:e92358
24. SAS Institute Inc. 2013. Base SAS® 9.4 Procedures Guide, Second Edition. Cary, NC: SAS Institute Inc.
25. SAS Institute Inc. 2013. SAS/STAT® 13.1 User’s Guide. Cary, NC: SAS Institute Inc.
26. Shen X, Xi G, Maile LA, Wai C, Rosen CJ, Clemmons DR (2012) Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase beta and the IGF-I receptor to regulate IGF-I-stimulated signaling. Mol Cell Biol 32:4116–4130
27. Wheatcroft SB, Kearney MT (2009) IGF-dependent and IGF-independent actions of IGF-binding protein-1 and −2: implications for metabolic homeostasis. Trends Endocrinol Metab 20:153–162
28. Wheatcroft SB, Kearney MT, Shah AM, Ezzat VA, Miell JR, Modo M, Williams SC, Cawthorn WP, Medina-Gomez G, Vidal-Puig A, Sethi JK, Crossey PA (2007) IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 56:285–294
29. Xi G, Solum MA, Wai C, Maile LA, Rosen CJ, Clemmons DR (2013) The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice. Endocrinology 154:4146–4157
30. Xi G, Wai C, DeMambro V, Rosen CJ, and Clemmons DR (2014). IGFBP-2 Directly Stimulates Osteoblast Differentiation. J. Bone Miner. Res
31. Yau SW, Henry BA, Russo VC, McConell GK, Clarke IJ, Werther GA, Sabin MA (2014) Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: evidence from nonrodent models. Endocrinology 155:2133–2143